COMMUNIQUÉS West-GlobeNewswire

IntelGenx to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
SAINT LAURENT, Quebec, Sept. 03, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that its CEO, Dr. Horst G [...]
Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the [...]
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
03/09/2019
DURHAM, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President & Chief Executive Officer, will present company overviews at two [...]
CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
BioCryst to Present at H.C. Wainwright Global Investment Conference
03/09/2019
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the H.C. Wainwright Global Investment Conference in New York [...]
DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
03/09/2019
MINNEAPOLIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that management will present at the 2019 Dougherty & Co. Institutional Investor Conference in Minneapolis, [...]
Turning Point Therapeutics Announces Proposed Public Offering of Common Stock
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing novel drugs to address treatment resistance, announced today it has filed a [...]
Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of [...]
GBT Announces Participation at the 2019 Morgan Stanley Global Healthcare Conference
03/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2019 Morgan Stanley Global Healthcare Conference in New [...]
Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference
03/09/2019
ALPHARETTA, Ga., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people [...]
Aduro Biotech to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
BERKELEY, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is scheduled to present at the H. [...]
Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
NextCure to Present at Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
BELTSVILLE, Md., Sept. 03, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/09/2019
BOSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
03/09/2019
MALVERN, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost [...]
Novan Hires Michelle Patterson as Vice President of Project Management
03/09/2019
Underscores Company’s preparation for potential NDA submission for SB206 in molluscum Role to lead cross-functional coordination of key activities and timelines for the program SB206 top line results are expected no [...]
Crinetics Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Stereotaxis Announces Uplisting to NYSE American
03/09/2019
ST. LOUIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that its common stock has been [...]
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
03/09/2019
MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]

Pages